Loading insider details...
Latest Form 4 (Oct 26, 2026): Sale of 513 ACRV shares, $943.92.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 26, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 513 | $943.92 |
| Oct 7, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 294 | $585.06 |
| Aug 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 185 | $371.85 |
| Jul 23, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 573 | $1.0K |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 49,830 | n/a |
| May 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 184 | $353.28 |
| Apr 21, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 558 | $993.24 |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 129,760 | n/a |
| Feb 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 217 | $353.71 |
| Jan 21, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 659 | $1.3K |